Enochian Biosciences, Inc.
ENOB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$178 | -$81 | -$39,684,056 | -$113 |
| Dep. & Amort. | $0 | $0 | $113,496 | $0 |
| Deferred Tax | $0 | $0 | -$3,894,955 | $0 |
| Stock-Based Comp. | $3 | $5 | $3,535,051 | $5 |
| Change in WC | $0 | $0 | $3,894,955 | $1 |
| Other Non-Cash | $167 | $65 | $24,260,960 | $91 |
| Operating Cash Flow | -$8 | -$11 | -$11,774,549 | -$16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$29,774 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$1 | -$1 | $0 | $0 |
| Investing Cash Flow | -$1 | -$1 | -$29,774 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2 | $1,200,000 | $5 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8 | $11 | $4,515,056 | $4 |
| Financing Cash Flow | $8 | $11 | $4,515,056 | $4 |
| Forex Effect | -$0 | $0 | -$8,395 | -$0 |
| Net Chg. in Cash | -$0 | -$2 | -$7,297,662 | -$11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $2 | $9,172,142 | $21 |
| End Cash | $0 | $0 | $1,874,480 | $9 |
| Free Cash Flow | -$8 | -$11 | -$11,804,323 | -$16 |